Yoga Intervention for Substance Use and ART Adherence in Community Reentry

Sponsor
University of Pennsylvania (Other)
Overall Status
Completed
CT.gov ID
NCT02492893
Collaborator
National Institute on Drug Abuse (NIDA) (NIH), Peter F. McManus Charitable Trust (Other), National Coalition of Independent Scholars (Other)
72
1
2
14
5.1

Study Details

Study Description

Brief Summary

People with HIV and a substance use disorder who are reentering the community from prison or jail face the dual risks of relapse and interruptions in adherence to antiretroviral therapy (ART) medication. This mixed-methods randomized controlled trial will compare the stress, substance use and ART adherence outcomes of participants in a 12-session, 90-minute weekly yoga group intervention with participants in a treatment as usual control group. All participants are re-entering the community, have HIV and experience substance use challenges.

Condition or Disease Intervention/Treatment Phase
  • Other: Hatha yoga
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Yoga Intervention for Substance Use and Antiretroviral Therapy Adherence in Community
Study Start Date :
Dec 1, 2014
Actual Primary Completion Date :
Feb 1, 2016
Actual Study Completion Date :
Feb 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Hatha Yoga

A 12-session 90-minute weekly hatha yoga intervention, that includes asanas (physical postures), pranayama (breathing exercises) and dhyana (meditation.

Other: Hatha yoga

No Intervention: Treatment as Usual

Outcome Measures

Primary Outcome Measures

  1. Stress: Perceived Stress Scale (self-report) [3 months]

  2. Substance use: Time Line Follow Back (self-report) [3 months]

Secondary Outcome Measures

  1. Antiretroviral therapy adherence: prescription refill (pharmacy data) [3 months]

  2. Heart rate: sphygmomanometer [3 months]

  3. Blood pressure: sphygmomanometer [3 months]

  4. Viral load: blood test [3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • have HIV

  • experience substance use challenges, within one year of reentry from prison or jail

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pennsylvania Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • University of Pennsylvania
  • National Institute on Drug Abuse (NIDA)
  • Peter F. McManus Charitable Trust
  • National Coalition of Independent Scholars

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT02492893
Other Study ID Numbers:
  • 820294
  • 1F31DA038429-01
First Posted:
Jul 9, 2015
Last Update Posted:
Apr 18, 2017
Last Verified:
Apr 1, 2017
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 18, 2017